Business Move Mitsui Chemicals Increases Biocatalysts Production

Source: Press release Mitsui Chemicals 1 min Reading Time

Related Vendors

Mitsui Chemicals’ subsidiary Polaris Chemicals has begun the production of biocatalysts which is used in the manufacture of acrylamide. With this, Mitsui Chemicals aims to increase its production capacity of biocatalysts.

Outside Polaris Chemicals’ factory (first shipment in July 2023). (Source:  Mitsui Chemicals)
Outside Polaris Chemicals’ factory (first shipment in July 2023).
(Source: Mitsui Chemicals)

Tokyo/Japan – Mitsui Chemicals has recently announced that Polaris Chemicals, a subsidiary company established between Mitsui Chemicals and Kasano Kosan Corporation, has begun production of biocatalysts used in the production of acrylamide. Acrylamide is a raw material for polyacrylamide, which is in turn used as a flocculant for wastewater treatment, a paper strengthening agent and a crude oil recovery agent, among other applications. With global demand for acrylamide steadily growing, Mitsui Chemicals’ acrylamide production biocatalysts have built up a good reputation among acrylamide manufacturers around the world, boosting sales and creating a need to increase production capacity.

The corresponding production capacity increase will be implemented through Polaris Chemicals. Kasano Kosan is a customer of Mitsui Chemicals’ acrylamide, taurine and other products. The new production facilities at Polaris are set to make use of the latest technologies and expertise from Mitsui Chemicals’ Omuta Works, the company’s mother plant for these operations.

Through the production capacity increase, Mitsui Chemicals aims to make major contributions toward society’s efforts to secure water resources and utilize sustainable resources, as well as toward its own goal of becoming the world’s number one manufacturer of acrylamide production biocatalysts.

(ID:49657637)

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy. The consent declaration relates, among other things, to the sending of editorial newsletters by email and to data matching for marketing purposes with selected advertising partners (e.g., LinkedIn, Google, Meta)

Unfold for details of your consent